| Non-Hodgkin Lymphoma by Clinical Course investigated in trials for …INVESTIGATED_IN_TRIALSderived154 of 154show fewer |
|---|
| → investigated in trials for | Rituximabmonoclonal antibody 194 trials (61 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 194 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyclophosphamidesmall molecule 147 trials (53 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 147 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 89 trials (24 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 89 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vincristinesmall molecule 73 trials (25 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 73 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Etoposidesmall molecule 70 trials (21 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 70 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisonesmall molecule 68 trials (29 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 68 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall molecule 64 trials (24 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 64 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenalidomidesmall molecule 59 trials (24 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 59 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dexamethasonesmall molecule 46 trials (14 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 46 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ibrutinibsmall molecule 40 trials (18 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 40 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Methotrexatesmall molecule 39 trials (10 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 39 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bortezomibsmall molecule 38 trials (3 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 38 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cytarabinesmall molecule 35 trials (12 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 35 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bendamustinesmall molecule 34 trials (12 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 34 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Obinutuzumabmonoclonal antibody 34 trials (16 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 34 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zanubrutinibsmall molecule 29 trials (19 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 29 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Venetoclaxsmall molecule 27 trials (16 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 27 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 22 trials (5 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegaspargaseother 22 trials (8 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal antibody 22 trials (8 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Filgrastimother 21 trials (4 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Melphalansmall molecule 17 trials (5 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Brentuximab Vedotinadc 16 trials (5 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 16 trials (5 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vorinostatsmall molecule 16 trials (2 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Busulfansmall molecule 15 trials (3 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Epcoritamabmonoclonal antibody 15 trials (12 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ifosfamidesmall molecule 15 trials (5 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Acalabrutinibsmall molecule 14 trials (9 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mogamulizumabmonoclonal antibody 14 trials (6 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mosunetuzumabmonoclonal antibody 14 trials (13 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 14 trials (5 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mercaptopurinesmall molecule 13 trials (7 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Azacitidinesmall molecule 12 trials (5 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Idelalisibsmall molecule 12 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ofatumumabmonoclonal antibody 11 trials (2 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Polatuzumab Vedotinadc 11 trials (9 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Romidepsinother 11 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sirolimussmall molecule 11 trials (2 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leucovorinsmall molecule 10 trials (3 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Oxaliplatinsmall molecule 10 trials (3 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alemtuzumabmonoclonal antibody 9 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carmustinesmall molecule 9 trials (2 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pirtobrutinibsmall molecule 9 trials (6 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alisertibsmall molecule 8 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Belinostatsmall molecule 8 trials (3 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Duvelisibsmall molecule 8 trials (3 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Everolimussmall molecule 8 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nelarabinesmall molecule 8 trials (2 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegfilgrastimother 8 trials (3 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tafasitamabmonoclonal antibody 8 trials (8 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carfilzomibother 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Inotuzumab Ozogamicinadc 7 trials (5 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pralatrexatesmall molecule 7 trials (3 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thalidomidesmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Copanlisibsmall molecule 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Glofitamabmonoclonal antibody 6 trials (5 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mechlorethaminesmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thioguaninesmall molecule 6 trials (3 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aldesleukinother 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Asparaginaseother 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Blinatumomabmonoclonal antibody 5 trials (4 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Clofarabinesmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Daratumumabmonoclonal antibody 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Daunorubicinsmall molecule 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lisocabtagene Maraleucelgene therapy 5 trials (3 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ruxolitinibsmall molecule 5 trials (4 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tanespimycinsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tazemetostatsmall molecule 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alvocidibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Axicabtagene Ciloleucelgene therapy 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Calaspargase Pegolother 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chemotherapy 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chlorambucilsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dasatinibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Decitabinesmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal antibody 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ixazomibsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Panobinostatsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pomalidomidesmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisolonesmall molecule 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selinexorsmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Anti-PD1 Monoclonal Antibody 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cemiplimabmonoclonal antibody 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cladribinesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Loncastuximab Tesirineadc 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pacritinibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pixantronesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Plerixaforsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sintilimabmonoclonal antibody 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temsirolimussmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thiotepasmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tislelizumabmonoclonal antibody 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Akt Inhibitor MK2206 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avelumabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bexarotenesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Buparlisibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Camrelizumabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ibritumomab Tiuxetanmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imatinib Mesylatesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imiquimodsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Interferon Alfa-2bother 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Irinotecansmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Perifosinesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenib Tosylatesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sugemalimabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tisagenlecleucelcell therapy 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Veliparibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vindesinesmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alvespimycinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aminolevulinic Acidsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Arsenic Trioxidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capecitabinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cediranibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chlormethinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enasidenibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enzastaurinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Epirubicinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | HDAC Inhibitor REC-2282 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | HyperCVAD Regimen 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Idarubicinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Immunomodulatory Oligonucleotide 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lomustinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mitoxantronesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | O6-Benzylguaninesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Obecabtagene Autoleucelgene therapy 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Odronextamabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Peginterferon Alfa-2bother 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemigatinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pentostatinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pidnarulexsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Procarbazinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Radiation Therapy 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Retifanlimabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sapanisertibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sunitinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tagraxofuspother 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Talimogene Laherparepvecgene therapy 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Teclistamabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Teniposidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tipifarnibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tofacitinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Topotecansmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Treosulfansmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Valproic Acidsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinblastinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinorelbinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vismodegibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma by Clinical Course | 1 | Observed | clinicaltrials | graph → |